So many sessions, so little time. Here are 10 presentations at ACC.15 that could change how you treat patients and do business from now on.

Innovative technologies that facilitate patient-centered care can help reduce deaths from cardiovascular disease. With research support, those technologies can be implemented broadly.  

Some statins may influence the development of diabetes more than previously believed. A study found that in a large population of men on statins, a significant number developed diabetes, with risk increasing in a dose-dependent manner.

A coffee habit may improve a patient’s cardiovascular profile. A study looking at coronary artery calcium (CAC) and coffee consumption found that those who drank three or four cups of coffee a day had lower CAC score ratios than those who consumed more or less.

The American College of Cardiology has launched version 2.0 of their Guideline Clinical App. With the addition of the healthy lifestyle and obesity guidelines, the app now contains the full set of clinical prevention guidelines released by ACC/American Heart Association in 2013. These additions expand the collection of clinical guidelines in the App which already includes guidelines on assessment of cardiovascular risk, treatment of blood cholesterol, atrial fibrillation, heart failure and valvular heart disease.

With national politicians unlikely to address the issue, hospitals need to act on their own to mitigate the increasing threat of active-shooter incidents like a recent fatal gunning of a Boston cardiac surgeon, according to a commentary. 

A study revealed that in one hospital, cardiac surgery-related phlebotomy was really draining its patients. Analyzing a possible link between blood draws and hospital-acquired anemia, researchers found that 74 percent of patients with normal values for hemoglobin on admission were anemic by discharge.

Truven Health Analytics named its top 100 hospitals for 2015, based on traditional performance measures such as 30-day readmission and mortality rates as well as a new metric on Medicare spending per beneficiary.